Effects of antidiabetic drugs that cause glucose excretion directly from the body on mortality
Diabetes is widespread worldwide, and there is concern that the mortality rate due to diabetes will increase. Until now, various antidiabetic drugs have been used to improve the pathological condition in diabetes patients. It has been reported that some antidiabetic drugs not only improve blood gluc...
Main Authors: | Hideya Shintani, Tomoya Shintani |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Medicine in Drug Discovery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S259009862030049X |
Similar Items
-
Theaflavins inhibit glucose transport across Caco-2 cells through the downregulation of the Ca2+/AMP-activated protein kinase-mediated glucose transporter SGLT1
by: Baorui Li, et al.
Published: (2020-12-01) -
GLP-1 RAs and SGLT2i: two antidiabetic agents associated with immune and inflammation modulatory properties through the common AMPK pathway
by: Alessio Mazzieri, et al.
Published: (2023-11-01) -
SGLT 2 inhibitors: Antidiabetic agents with promising effects beyond glucose control
by: Canan Ersoy
Published: (2020-01-01) -
Diagnostic Performance of Dynamic Whole-Body Patlak [<sup>18</sup>F]FDG-PET/CT in Patients with Indeterminate Lung Lesions and Lymph Nodes
by: Matthias Weissinger, et al.
Published: (2023-06-01) -
Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension
by: Xiaojun Chen, et al.
Published: (2024-05-01)